According to a new report, published by KBV research, The Global Femtech Market size is expected to reach $10.1 billion by 2028, rising at a market growth of 10.6% CAGR during the forecast period.
The Mobile Apps market is showcasing a CAGR of 12.9% during (2022 - 2028). It is because of the emerging trend of precautionary healthcare and increasing smartphone penetration along with better internet connectivity is estimated to fueling the consumer adoption of smartphone health applications across the world. The need for women's health mobile applications is increasing as network infrastructure improves and coverage expands. With the increased usage of smartphones, driving growth to meet unmet needs (women's health gaps), growing healthcare consciousness, and increasing awareness about health and well-being, especially among women, mobile network operators see health applications as a lucrative investment opportunity.
The North America market dominated the Global Femtech Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3.9 billion by 2028. The Europe market is estimated to witness a CAGR of 10.3% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 11.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/femtech-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Google LLC, HeraMED Ltd., iSono Health, Inc., Clue by Biowink GmbH, Chiaro Technology Ltd., Natural Cycles USA Corp., Flo Health UK Limited, Glow, Inc., and Withings France SA.
By Product Type
By Geography
Companies Profiled
Unique Offerings 
